Long-Term Proactive Management of Psoriasis Vulgaris with Fixed-Dose Combination of Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam: Results from a Phase III Randomized Controlled Trial. J of Skin [Internet]. 2020 Sep. 2 [cited 2026 May 1];4(5):s32. Available from: https://skin.dermsquared.com/skin/article/view/981